J Clin Invest. 1992 Jun;89(6):1892-901. doi: 10.1172/JCI115794.

Aberrant integrin expression during epidermal wound healing and in psoriatic epidermis.

The Journal of clinical investigation

M D Hertle, M D Kubler, I M Leigh, F M Watt

PMID: 1601996 PMCID: PMC295888 DOI: 10.1172/JCI115794
Free PMC Article

Abstract

We have examined integrin expression during the remodeling of the epidermis that takes place during wound healing, using a suction blister model in which the epidermis is detached from the dermis, leaving the basement membrane intact. By immunofluorescence microscopy, we found that the same integrin subunits were expressed during wound healing as in normal epidermis with very little change in the relative intensity or distribution of staining at the leading edge of the migrating epidermis. However, at the time of wound closure, when the epidermis is still hyperproliferative, alpha 2, alpha 3, alpha 6, and beta 1 were no longer confined to the basal layer, as in normal epidermis, but were also found in all the living suprabasal cell layers, coexpressed with the terminal differentiation markers involucrin, keratin 10, and keratin 16. Strong suprabasal staining for alpha v was also found in one specimen. beta 4, which normally forms a heterodimer with alpha 6, and alpha 5 remained predominantly basal. Three of the integrin ligands, fibronectin, type IV collagen, and laminin, remained largely confined to the basement membrane zone and dermis. By 14 d after wounding, the integrins were once more restricted to the basal layer. Suprabasal integrin expression was also observed in involved psoriatic lesions. Thus, in two situations in which the epidermis is hyperproliferative, there is a failure to downregulate integrin expression on initiation of terminal differentiation. The functional consequences of this aberrant integrin expression remain to be explored.

Similar articles

Cited by

References

1. Cell. 1991 May 3;65(3):409-16 - PubMed
2. J Invest Dermatol. 1967 May;48(5):466-77 - PubMed
3. J Cell Sci. 1990 Jun;96 ( Pt 2):197-205 - PubMed
4. Cell. 1990 Oct 19;63(2):425-35 - PubMed
5. J Cell Biol. 1990 Dec;111(6 Pt 2):3141-54 - PubMed
6. Lab Invest. 1990 Dec;63(6):825-31 - PubMed
7. Proc Natl Acad Sci U S A. 1990 Nov;87(22):8970-4 - PubMed
8. Dermatol Clin. 1990 Oct;8(4):649-61 - PubMed
9. J Invest Dermatol. 1987 Sep;89(3):253-63 - PubMed
10. Br J Dermatol. 1986 Mar;114(3):279-83 - PubMed
11. J Cell Biol. 1988 Nov;107(5):1881-91 - PubMed
12. Cell. 1987 Feb 27;48(4):549-54 - PubMed
13. J Invest Dermatol. 1985 Oct;85(4):304-8 - PubMed
14. Adv Dermatol. 1989;4:277-99; discussion 300 - PubMed
15. Nature. 1989 Jul 27;340(6231):307-9 - PubMed
16. J Cell Biol. 1988 Aug;107(2):427-46 - PubMed
17. J Cell Sci Suppl. 1987;8:199-209 - PubMed
18. J Invest Dermatol. 1990 Nov;95(5 Suppl):18S-19S - PubMed
19. Development. 1991 May;112(1):193-206 - PubMed
20. J Cell Sci. 1992 Jan;101 ( Pt 1):1-5 - PubMed
21. J Invest Dermatol. 1991 Sep;97(3):562-7 - PubMed
22. J Cell Sci. 1990 Jun;96 ( Pt 2):207-17 - PubMed
23. J Cell Sci. 1991 Feb;98 ( Pt 2):225-32 - PubMed
24. J Cell Biol. 1991 Feb;112(4):761-73 - PubMed
25. J Cell Biol. 1991 Dec;115(6):1737-50 - PubMed
26. J Cell Biol. 1991 Nov;115(3):829-41 - PubMed
27. Exp Cell Res. 1991 Aug;195(2):315-22 - PubMed
28. Br J Dermatol. 1991 Jun;124(6):513-8 - PubMed
29. J Immunol. 1991 Jul 1;147(1):369-74 - PubMed
30. J Cell Biol. 1991 Jun;113(5):981-6 - PubMed
31. Curr Eye Res. 1991 Jan;10(1):75-85 - PubMed
32. J Cell Biol. 1991 May;113(4):907-17 - PubMed
33. J Cutan Pathol. 1991 Feb;18(1):8-12 - PubMed
34. J Biol Chem. 1989 Sep 15;264(26):15515-21 - PubMed
35. Arch Dermatol Res. 1987;279(5):335-40 - PubMed
36. J Histochem Cytochem. 1986 Aug;34(8):1037-46 - PubMed
37. J Invest Dermatol. 1986 May;86(5):585-90 - PubMed
38. J Clin Invest. 1989 Dec;84(6):1916-23 - PubMed
39. J Cell Biol. 1989 Aug;109(2):863-75 - PubMed
40. J Biol Chem. 1989 Nov 15;264(32):18859-62 - PubMed
41. Cancer Res. 1986 Dec;46(12 Pt 1):6446-51 - PubMed
42. J Biol Chem. 1987 Nov 5;262(31):15158-65 - PubMed
43. J Invest Dermatol. 1987 Oct;89(4):349-52 - PubMed
44. J Invest Dermatol. 1985 Oct;85(4):309-13 - PubMed
45. Cancer Res. 1985 Nov;45(11 Pt 2):5663-9 - PubMed
46. J Cell Biol. 1990 Apr;110(4):1387-404 - PubMed
47. J Cell Biol. 1990 Mar;110(3):803-15 - PubMed
48. J Invest Dermatol. 1990 Jun;94(6 Suppl):128S-134S - PubMed
49. J Invest Dermatol. 1990 Jun;94(6):793-7 - PubMed
50. Annu Rev Immunol. 1990;8:365-400 - PubMed
51. Exp Cell Res. 1990 Apr;187(2):277-83 - PubMed
52. Proc Natl Acad Sci U S A. 1990 Sep;87(17):6888-92 - PubMed
53. J Cell Biol. 1984 Apr;98(4):1397-406 - PubMed
54. Virchows Arch A Pathol Anat Histol. 1981;392(2):217-30 - PubMed
55. Cell. 1980 Apr;19(4):1033-42 - PubMed
56. J Cell Biol. 1984 Jan;98(1):16-21 - PubMed
57. Exp Cell Res. 1982 Feb;137(2):373-80 - PubMed
58. J Invest Dermatol. 1981 Aug;77(2):240-3 - PubMed
59. Arch Dermatol. 1967 Apr;95(4):408-11 - PubMed
60. Br J Dermatol. 1972 Jan;86(1):14-9 - PubMed
61. J Invest Dermatol. 1968 Apr;50(4):308-14 - PubMed
62. Br J Dermatol. 1974 May;90(5):481-90 - PubMed
63. J Cell Biol. 1968 Oct;39(1):135-51 - PubMed
64. J Clin Invest. 1991 Jan;87(1):1-5 - PubMed

Substances

• Extracellular Matrix Proteins
• Integrins

MeSH terms

• Blister / metabolism
• Cell Differentiation
• Cell Movement
• Epidermis / metabolism
• Epidermis / pathology
• Extracellular Matrix Proteins / metabolism
• Humans
• Integrins / metabolism
• Keratinocytes / cytology
• Psoriasis / metabolism
• Psoriasis / pathology
• Reference Values
• Wound Healing / physiology

Publication Types

• Journal Article

LinkOut - more resources

• Full Text Sources
  • American Society for Clinical Investigation
  • Europe PubMed Central
  • PubMed Central
• Medical
  • MedlinePlus Health Information
• Research Materials
  • NCI CPTC Antibody Characterization Program
• Other Literature Sources
  • The Lens - Patent Citations